On the kidneys, a pooled analysis of Phase 2 obesity and type 2 diabetes data showed reductions in the standard kidney-injury marker (the urine albumin-to-creatinine ratio, or UACR) of approximately 37% in adults with type 2 diabetes and 31.5% in adults with obesity but no type 2 diabetes, both on the 12 mg dose [12]
Usage tips: Whether using the autoinjector or a syringe, its best to rotate injection sites (abdomen, thigh, etc.) to minimize local irritation
What are the MOQ, sample quantity, lead time and change-control terms
Your journey to better health is unique, and Eden is here to support you every step of the way to make real progress toward your health goals. Results vary
Methods: Through our in vivo RNAi functional screening and validation platform, we discovered and validated ITFG1 as a therapeutic target for enhancing liver regeneration